Elixir Pharmaceuticals news from FierceBiotech
NewsElixir drops IPO, Aldagen launches IPO
Elixir Pharmaceuticals has dropped its bid for an $86 million IPO, saying that Read more...
| Press ReleasesPRESS RELEASE: Elixir Pharmaceuticals Plans $86.25 Million IPO Elixir Pharmaceuticals Plans $86.25 Million IPO CAMBRIDGE, Mass. -- Elixir Pharmaceuticals, Inc. announced today that it has filed a registration statement with the Securities and Exchange Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends